Use of Erythropoietin to Expand Regulatory T Cells in Autoimmune Liver Disease
Status:
Completed
Trial end date:
2021-02-18
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of erythropoietin on the number and function of regulatory T
cells in adults with autoimmune hepatitis. Participants will receive a single dose of
erythropoietin, and then the investigators will collect blood at different time points for
analysis of regulatory T cell number and function.
Phase:
Early Phase 1
Details
Lead Sponsor:
Northwestern University
Collaborators:
Icahn School of Medicine at Mount Sinai Mount Sinai Hospital, New York